Reed Elizabeth E's Form 4 filing
Travere Therapeutics, Inc. (TVTX) · filed May 12, 2022
- Accession no.
- 0001209191-22-028708
- Filed
- May 12, 2022
- Trade date
- May 10-12, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $41.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Reed Elizabeth ECIK 0001283303 | Officer (SVP, GC & Corporate Secretary) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 10, 2022 | Common Stock | SSaleDisposed | −900 | $21.51 | −$19,359 | 42,888 | Direct | |
| May 12, 2022 | Common Stock | SSaleDisposed | −1,050 | $21.51 | −$22,585.5 | 41,838 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.